Odyssean LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Odyssean LLC's REGN Position: Q3 2026 in Review
Odyssean LLC opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 5,805 shares worth $4.4M. The stake represents 0.51% of the portfolio and ranks #22 among its holdings. This is a return to the name: Odyssean LLC previously reported a position in REGN as recently as Q1 2026.
Odyssean LLC first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. 1,433 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Odyssean LLC held 5,805 shares of Regeneron Pharmaceuticals worth $4.4M as of Q3 2026.
- Regeneron Pharmaceuticals was a new Odyssean LLC position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.51% of Odyssean LLC's portfolio in Q3 2026, its #22 holding.
- Odyssean LLC first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,433 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.